Many HGSCs display rich tumor infiltration of CD8+ effector T lymphocytes, which is prognostically beneficial [4, 5], but treatment with immune checkpoint inhibitors (ICI) has shown limited efficacy in this entity. This evidence concerns the gene CD8A and neoplasm.